African Journal of Infectious Diseases Research

ISSN 2756-3340

African Journal of Infectious Diseases Research | Vol. 13, No. 3, March 2026 | pp. 155–161

DOI: 10.46882/AJIDR/148933

Article Type: Research Article

Title: Molecular epidemiology and antifungal susceptibility of Pichia kudriavzevii isolated from invasive candidemia in hematologic malignancy patients

Names of Authors: Thabo Mokoena¹*, Lukas Weber², Kenji Takahashi³

Authors’ Affiliations: ¹Department of Hematology, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Mycology, University of Zurich, Zurich, Switzerland. ³Department of Infectious Diseases, Nagasaki University, Nagasaki, Japan.

Abstract: Pichia kudriavzevii (formerly Candida krusei) is an intrinsically fluconazole-resistant opportunistic yeast causing breakthrough fungemia in neutropenic cancer patients receiving triazole prophylaxis. We determined incidence rates, molecular genotypes, and antifungal susceptibility profiles of P. kudriavzevii bloodstream isolates. A total of 58 clinical isolates from hematology-oncology wards were analyzed via microsatellite typing and broth microdilution testing. Intrinsic fluconazole resistance was universal, while voriconazole, caspofungin, and liposomal amphotericin B demonstrated 94.8 percent, 98.3 percent, and 100 percent susceptibility, respectively. Empirical echinocandin initiation is recommended for febrile neutropenic patients on azole prophylaxis.

Keywords: Pichia kudriavzevii, Candidemia, Hematologic malignancy, Intrinsic fluconazole resistance, Echinocandins

Citation: Mokoena T, Weber L, Takahashi K (2026). Molecular epidemiology and antifungal susceptibility of Pichia kudriavzevii isolated from invasive candidemia in hematologic malignancy patients. African Journal of Infectious Diseases Research, 13(3): 155–161. DOI: 10.46882/AJIDR/148933

Manuscript Timeline: Received: January 18, 2026; Revised: February 19, 2026; Accepted: March 03, 2026; Published: March 09, 2026